Advanced search
Publication Cover
Platelets Volume 33, 2022 - Issue 4
Submit an article Journal homepage
287
Views
6
CrossRef citations to date
0
Altmetric
Rapid Article

New presentations and exacerbations of immune thrombocytopenia after coronavirus disease 2019 vaccinations: the Taiwan experience

Sheng-Chieh Chou1 Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, ROCView further author information
,
Yu-Cheng Chang2 Division of Hematology and Oncology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan, ROCView further author information
,
Chun-Kai Liao3 Department of Internal Medicine, Hematology-Oncology Division, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan, ROCView further author information
,
Tsung-Chih Chen4 Division of Hematology/Medical Oncology, Department of Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, ROCView further author information
,
Kuo-Jui Sun1 Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, ROCView further author information
,
Wei-Han Huang5 Department of Clinical Pathology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan, ROC;6 Department of Hematology and Oncology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan, ROCView further author information
&
Yi-Feng Wu6 Department of Hematology and Oncology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan, ROC;7 College of Medicine, Tzu-Chi University, Hualien, Taiwan, ROCCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1073-9194View further author information
ORCID Icon show all
Pages 531-535 | Received 29 Nov 2021, Accepted 20 Jan 2022, Published online: 23 Feb 2022

References

  • Krammer F. SARS-CoV-2 vaccines in development. Nature 2020;586:516–527. Epub 2020/09/24. doi:10.1038/s41586-020-2798-3
  • Pavord S, Scully M, Hunt BJ, Lester W, Bagot C, Craven B, Rampotas A, Ambler G, Makris M. Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. N Engl J Med 2021;385:1680–1689. Epub 2021/08/12. doi:10.1056/NEJMoa2109908
  • Simpson CR, Shi T, Vasileiou E, Katikireddi SV, Kerr S, Moore E, McCowan C, Agrawal U, Shah SA, Ritchie LD, et al. First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nat Med 2021;27:1290–1297. Epub 2021/06/11. doi:10.1038/s41591-021-01408-4
  • Paulsen FO, Schaefers C, Langer F, Frenzel C, Wenzel U, Hengel FE, Bokemeyer C, Seidel C. Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19). Blood 2021;138:996–999. Epub 2021/07/24. doi:10.1182/blood.2021012790
  • Akiyama H, Kakiuchi S, Rikitake J, Matsuba H, Sekinada D, Kozuki Y, Iwata N. Immune thrombocytopenia associated with Pfizer-BioNTech’s BNT162b2 mRNA COVID-19 vaccine. IDCases 2021;25:e01245. Epub 2021/08/13. doi:10.1016/j.idcr.2021.e01245
  • Candelli M, Rossi E, Valletta F, De Stefano V, Franceschi F. Immune thrombocytopenic purpura after SARS-CoV-2 vaccine. Br J Haematol 2021;194:547–549. Epub 2021/05/03. doi:10.1111/bjh.17508
  • Shah SRA, Dolkar S, Mathew J, Vishnu P. COVID-19 vaccination associated severe immune thrombocytopenia. Exp Hematol Oncol 2021;10:42. Epub 2021/07/17. doi:10.1186/s40164-021-00235-0
  • Welsh KJ, Baumblatt J, Chege W, Goud R, Nair N. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine 2021;39:3329–3332. Epub 2021/05/20. doi:10.1016/j.vaccine.2021.04.054
  • Scanvion Q, Lambert M, Hachulla E, Terriou L. Correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS-CoV-2 vaccine. Br J Haematol 2021;194:e93–e95. Epub 2021/06/12. doi:10.1111/bjh.17628
  • Kuter DJ. Exacerbation of immune thrombocytopenia following COVID-19 vaccination. Br J Haematol 2021;195:365–370. Epub 20210624. doi:10.1111/bjh.17645
  • Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Perez Marc G, Moreira ED, Zerbini C, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020;383:2603–2615. Epub 2020/12/11. doi:10.1056/NEJMoa2034577
  • Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 2021;384:403–416. Epub 2020/12/31. doi:10.1056/NEJMoa2035389
  • Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet 2021;397:99–111.
  • Hsieh SM, Liu MC, Chen YH, Lee WS, Hwang SJ, Cheng SH, Ko WC, Hwang KP, Wang NC, Lee YL, et al. Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan. Lancet Respir Med 2021;9:1396–1406. Epub 2021/10/17. doi:10.1016/S2213-2600(21)00402-1
  • Muir KL, Kallam A, Koepsell SA, Gundabolu K. Thrombotic thrombocytopenia after Ad26.COV2.S vaccination. N Engl J Med 2021;384:1964–1965. Epub 2021/04/15. doi:10.1056/NEJMc2105869
  • Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med 2021;384:2092–2101. Epub 2021/04/10. doi:10.1056/NEJMoa2104840
  • Schultz NH, Sorvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, Wiedmann M, Aamodt AH, Skattor TH, Tjonnfjord GE, et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med 2021;384:2124–2130. Epub 2021/04/10. doi:10.1056/NEJMoa2104882
  • Sorvoll IH, Horvei KD, Ernstsen SL, Laegreid IJ, Lund S, Gronli RH, Olsen MK, Jacobsen HK, Eriksson A, Halstensen AM, et al. An observational study to identify the prevalence of thrombocytopenia and anti-PF4/polyanion antibodies in Norwegian health care workers after COVID-19 vaccination. J Thromb Haemost 2021;19:1813–1818. Epub 2021/04/29. doi:10.1111/jth.15352

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.